cervical-cancer

Rural Nepali Indigenous women want HPV vaccines—but barely know what cervical cancer is.

Survey of 250 Indigenous women in rural Nepal found only 18% knew one prevention behavior for cervical cancer, yet 76.8% were positive toward screening and 81.6% toward HPV vaccination. The barrier is information, not willingness. Culturally tailored health education programs are urgently needed.

Rural Nepali Indigenous women want HPV vaccines—but barely know what cervical cancer is.

Key Findings

Only 18% knew at least one cervical cancer prevention behavior
76.8% had positive attitudes toward screening; 81.6% toward vaccination
Knowledge deficit—not cultural resistance—is the primary barrier
Cervical cancer is the leading cancer killer of Nepali women

Implications

Targeted health literacy programs could rapidly increase HPV vaccination and screening uptake.

Caveats

Small convenience sample (n=250); cross-sectional; abstract-only. May not generalize beyond these communities.

Source: Health promotion international — 2026-03-02

Landmark DCIS trial, CRC microbiome & AML combos

Two themes cut across this week’s 236 posts. The first is de-escalation: researchers are building rigorous evidence that patients can safely do less — skip lymph node surgery, forgo radiotherapy, watch pre-invasive lesions instead of cutting them out. The landmark result here is a randomized trial confirming that active surveillance

Colorectal Cancer Microbiome Discovery Platform

Analysis of 9,000+ patients revealed that only colorectal cancer — not other cancer types — consistently harbors distinct microbial communities, suggesting the gut microbiome has a unique relationship with colorectal carcinogenesis that could be exploited for diagnostics and treatment.

GBM Tumor Microenvironment Drug Target Atlas

Non-cancerous brain support cells were found to promote glioblastoma growth through paracrine signaling, and blocking this communication dramatically slowed tumor growth — revealing that GBM's microenvironment contains targetable vulnerabilities that are being systematically overlooked by drug…

BET Inhibitor Target Selectivity Database

BRD2 and BRD4 have fundamentally distinct functions — BRD2 prepares genes for activation while BRD4 triggers transcription — meaning that pan-BET inhibitors have been disrupting gene regulation in counterproductive ways, and the field now needs selective BRD4 inhibitors.

Rural Nepali Indigenous women want HPV vaccines—but barely know what cervical cancer is.

Key Findings

Implications

Caveats

Read more

Landmark DCIS trial, CRC microbiome & AML combos

Colorectal Cancer Microbiome Discovery Platform

GBM Tumor Microenvironment Drug Target Atlas

BET Inhibitor Target Selectivity Database